Breastcancerchoices.org
Innovative Research and Patient Advocacy
Your Donation  Helps
Our Research And
Advocacy Programs

Your Donation is Tax
Deductible
Please Make
Checks Payable to:

Breast Cancer
Choices, Inc.
PO Box 1567
Amagansett, NY
11930
Breast Cancer Choices, Inc., is a registered nonprofit organization.
Support our
Iodine Investigation Project by buying your Iodoral here.













180 tablets (12.5 mg) $33.95 + $6.95 flat rate shipping, any quantity.
Flat rate shipping for any amount within the US!









90 tablets (12.5 mg) $22.95 + $4.95 shipping.





----------------------
Directions:

Inform your health care practitioner when taking Iodoral or any nutritional supplement.

Iodoral Description from Package Insert

One tablet of Iodoral supplies an amount of total elemental iodine, comparable to the average daily intake of this essential element by mainland Japanese, a population with a very low
prevalence of fibrocystic disease of the breast and breast cancer.

I. GENERAL INFORMATION

Iodine is an essential element. Although its main function is in the production of thyroid
hormones by the thyroid gland, other organs in the body have a need for iodine in order to
function normally (4).

Several studies have demonstrated a relationship between low iodine intake and fibrocystic
disease of the breast (FDB), both in women and laboratory animals (1,2). The minimum amount
of iodine required for control and prevention of FDB is equivalent to 0.1mg/kg body weight/day.
For example, for a 50 kg woman, the daily amount of iodine would be 5 mg. The thyroid gland
needs iodide to function properly. The original study done 80 years ago to control goiter in
adolescent girls used 9 mg iodide daily (3).

During the early 1900's, the iodine/iodide solution called Lugol solution was used extensively,
effectively and safely in medical practice, for both low activity and above normal activity of the
thyroid gland (4). The recommended daily intake for iodine supplementation was 2 to 6 drops of
Lugol solution containing 12.5 to 37.5 mg total iodide. That amount was mentioned as lately as
1995 in a book on Pharmaceutical Sciences (5). Several investigators have shown convincing
evidence connecting inadequate iodine intake and breast cancer (6). Japanese women living in
Japan consumed a daily average of 13.8 mg total elemental iodine and they experience one of
the lowest prevalence (risk) for breast, ovarian and uterine cancer (6). In the 1960's, one slice of
bread in the USA contained the full RDA of 0.15 mg iodine. The risk for breast cancer was then 1
in 20 (7). Over the last 2 decades, iodine was replaced by bromine in the bread making process.
Bromine blocks thyroid function and may interfere with the anticancer effect of iodine on the
breast (4). Now, the risk for breast cancer is 1 in 8 and increasing 1% per year (7).

The RDA limits for vitamins and minerals were established after World War II. One of the last
essential elements included in the RDA system was iodine, established in 1980 and confirmed
in 1989 (8). The RDA for iodine was based on the amount of iodine/iodide needed to prevent
goiter, extreme stupidity and hypothyroidism (9). The optimal requirement of the whole human
body for iodine has never been studied. Therefore, the optimal amount of this element for
physical and mental wellbeing is unknown. Based on demographic studies, the mainland
Japanese consumed an average of 13.8 mg daily and they are one of the healthiest people on
planet earth (6). Lugol solution is a time-tested preparation with a proven track record for over
150 years. Two drops contain 12.5 mg iodine/iodide, an amount very close to the 13.8 mg
average intake of mainland Japanese.

II. RATIONALE FOR THIS

FORMULATION

Administration of iodine/iodide in liquid solution is not very accurate, may stain clothing, has an
unpleasant taste and causes gastric irritation. Iodoral® is a precisely quantified tablet form
containing 5 mg iodine and 7.5 mg iodide as the potassium salt. To prevent gastric irritation, the
iodine/iodide preparation was absorbed unto a colloidal silica excipient; and to eliminate the
unpleasant taste of iodine, the tablets were coated with a thin film of pharmaceutical glaze (10).

III. SUGGESTED USE

The suggested daily amount is 1-4 tablets/day as recommended by your physician. Work closely
with your physician while on the Iodoral® program. Report to your physician any history of thyroid
surgery and/or radiation, chronic lymphocytic thyroiditis (Hashimoto), and any previous problem
with your thyroid. Before starting Iodoral®, your physician (He/She = He) will order blood tests for
hematology, blood chemistry and thyroid functions. He will also perform an ultrasound of your
thyroid to measure the size and appearance of your thyroid. Depending on the results of the
thyroid function tests and ultrasound, he may order some blood tests for thyroid antibodies. If you
are taking thyroid hormones, let your physician know about it. Be aware that Iodoral® enhances
the response of your body to thyroid hormones (4,6). Subjects on Iodoral® feel warmer in cold
environments and that is expected. However, you will need to cut down the amount of thyroid
hormones if you experience palpitation, anxiety, increased sweating and intolerance to heat. That
is because Iodoral® decreases your need for thyroid hormones. Your physician will guide you in
titrating downward the amount of thyroid hormones. Your physician will reevaluate you one
month afterward if you are on thyroid hormones, and 3 months if not. Keep a record of what you
observe while on Iodoral® and show it to your physician.

To test whole body sufficiency for iodine, 4 tablets of Iodoral® are ingested, followed by 24 hr.
urine collection. The more deficient a subject is in iodine, the more iodine is retained by the body
and the least excreted in the urine. Sufficiency is achieved when 90% or more of the ingested
amount is excreted in the urine. In most subjects tested, 3-4 tablets of Iodoral®/day were
required to achieve whole body sufficiency within 3 months and the body retained approximately
1.5 gm iodine at sufficiency (4,8). The best response in patients with FDB was observed with
ingestion of 2 tablets twice a day (8). Check with your physician for more information about the
loading test.
IV. REFERENCES

1) Ghent, W., et al, Can. J. Surg., 36:453-460,1993.

2) Eskin, B., et al, Biological Trace Element Research, 49:9-19, 1995.

3) Marine, D., Atl. Med. J., 26:437-442, 1923.

4) Abraham,G.E., The Original Internist, 11:17-36, 2004.

5) Gennaro A.R., Remington: 19th Edition, 1995, Mack Publishing Co, 1267.

6) Abraham, G.E., Flechas, J.D., Hakala, J.C., The Original Internist, 9:30-41, 2002.

7) Epstein, S.S., et al, Breast Cancer Prevention Program Macmillan, NY, 1998, pg5.

8) Abraham, G.E., The Original Internist, 11:(2) 29-38, 2004.

9) Abraham, G.E. Townsend Letter, 245:100-101, 2003.

10) Abraham, G.E., Flechas, J.D., Hakala, J.C., The Original Internist, 9:5-20, 2002.

V. POTENTIAL SIDE EFFECTS

Ingestion of iodine and/or iodide has been associated with certain complaints. If you experience
any of the following, stop ingesting Iodoral® and contact your physician:

• acne-like skin lesions in certain areas of your body

• headache in the frontal sinus

• unpleasant brassy taste

• increased salivation and sneezing

If you experience any unusual symptom since starting on Iodoral®, contact your physician

Web page updated December 10, 2007
  • To pay by Paypal click on the Buy Now
    button.  All sales final.

  • We ship twice daily, six days a week.

  • US checks also accepted. All sales final.

  • Price for orders shipped only within the US.


    or for shipping rates outside the US.